Business Description
Pharma Resources (Shanghai) Co Ltd
ISIN : CNE1000065Q9
Share Class Description:
SZSE:301230: Class ACompare
Compare
Traded in other countries / regions
301230.China IPO Date
2022-11-01Description
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.4 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 7.42 | |||||
Interest Coverage | 3.24 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 6.49 | |||||
Beneish M-Score | -1.95 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.5 | |||||
3-Year EBITDA Growth Rate | -5.7 | |||||
3-Year EPS without NRI Growth Rate | -24.6 | |||||
3-Year Book Growth Rate | 47.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.01 | |||||
9-Day RSI | 27.27 | |||||
14-Day RSI | 33.96 | |||||
6-1 Month Momentum % | -1.67 | |||||
12-1 Month Momentum % | -34.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.96 | |||||
Quick Ratio | 3.64 | |||||
Cash Ratio | 2.84 | |||||
Days Inventory | 73.55 | |||||
Days Sales Outstanding | 60.57 | |||||
Days Payable | 76.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.64 | |||||
Dividend Payout Ratio | 1.87 | |||||
Forward Dividend Yield % | 1.64 | |||||
5-Year Yield-on-Cost % | 1.64 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -1.63 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.99 | |||||
Operating Margin % | 4.43 | |||||
Net Margin % | 5.21 | |||||
FCF Margin % | -36.01 | |||||
ROE % | 2.33 | |||||
ROA % | 1.83 | |||||
ROIC % | 3.72 | |||||
ROC (Joel Greenblatt) % | 5.08 | |||||
ROCE % | 2.22 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 107.35 | |||||
Forward PE Ratio | 27.02 | |||||
PE Ratio without NRI | 96.41 | |||||
PEG Ratio | 4.61 | |||||
PS Ratio | 5.72 | |||||
PB Ratio | 2.51 | |||||
Price-to-Tangible-Book | 2.53 | |||||
Price-to-Operating-Cash-Flow | 175.74 | |||||
EV-to-EBIT | 89.03 | |||||
EV-to-EBITDA | 89.03 | |||||
EV-to-Revenue | 5.03 | |||||
EV-to-FCF | -15.97 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.57 | |||||
Price-to-Graham-Number | 3.29 | |||||
Price-to-Net-Current-Asset-Value | 7.85 | |||||
Price-to-Net-Cash | 17.89 | |||||
Earnings Yield (Greenblatt) % | 1.12 | |||||
FCF Yield % | -6.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharma Resources (Shanghai) Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 499.051 | ||
EPS (TTM) (Â¥) | 0.185 | ||
Beta | 0 | ||
Volatility % | 60.65 | ||
14-Day RSI | 33.96 | ||
14-Day ATR (Â¥) | 0.992871 | ||
20-Day SMA (Â¥) | 22.279 | ||
12-1 Month Momentum % | -34.76 | ||
52-Week Range (Â¥) | 16.276923 - 42.3 | ||
Shares Outstanding (Mil) | 139.59 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharma Resources (Shanghai) Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharma Resources (Shanghai) Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Pharma Resources (Shanghai) Co Ltd Frequently Asked Questions
What is Pharma Resources (Shanghai) Co Ltd(SZSE:301230)'s stock price today?
The current price of SZSE:301230 is ¥19.86. The 52 week high of SZSE:301230 is ¥42.30 and 52 week low is ¥16.28.
When is next earnings date of Pharma Resources (Shanghai) Co Ltd(SZSE:301230)?
The next earnings date of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) is .
Does Pharma Resources (Shanghai) Co Ltd(SZSE:301230) pay dividends? If so, how much?
The Dividend Yield %  of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) is 1.64% (As of Today), Highest Dividend Payout Ratio of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) was 1.87. The lowest was 1.85. And the median was 1.85. The  Forward Dividend Yield % of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) is 1.64%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |